A new study reveals that the popular diabetes and weight-loss drug Ozempic might hold the key to relieving chronic migraines, ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

The obesity drug liraglutide cut migraine days in half in a small trial, though more research is needed to exclude the placebo effect, researchers said.

People with unresponsive chronic migraine and obesity experienced substantial relief after they started taking a GLP-1 drug, researchers in Italy have found.

The exact numbers depended on the type of medication patients took, but the risk of developing Alzheimer’s was up to 70 ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say liraglutide, a GLP-1RA, might help migraine by reducing intracranial ...

Already a household name in diabetes and weight management, Ozempic (semaglutide) may soon find another surprising role — as ...

Despite a multitude of treatment options, some migraine sufferers cannot find relief ... Ozempic-like drug significantly reduces frequency of chronic migraines in pilot study (2025, July ...

Study finds the GLP-1 drug liraglutide reduced migraine days by almost 50% in patients with obesity, with quality of life ...

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this widespread impact, many sufferers find current preventive treatments ...